DOTmed February 26, 2024
More than a year after announcing that it would spin off its patient monitoring and respiratory interventions businesses as a standalone company, Medtronic has pulled a 180, instead choosing to combine the units into a new segment within its main company.
It announced the news on February 20 and saw its stock close 1.7% on the New York Stock Exchange that day, reported the StarTribune.
The new unit will be called acute care and monitoring (ACM) and will include products from both businesses, except for the respiratory interventions’ line of ventilators, which Medtronic will phase out due to the products being “increasingly unprofitable,” according to its Q3 fiscal 2024 earnings report.
“Medtronic will continue to honor existing ventilator contracts to...